Matches in SemOpenAlex for { <https://semopenalex.org/work/W203873669> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W203873669 endingPage "69" @default.
- W203873669 startingPage "63" @default.
- W203873669 abstract "OBJECTIVES: We report our experience in the use of radionuclides in the treatment of bone metastases in patients with various primary cancers: breast cancer, prostate cancer, lung cancer, etc. MATERIAL AND METHODS: Eighty-seven patients (53 women, 34 men) with bone metastases were treated for pain relief with either 32-P (71 patients) or 89-Sr (16 patients). Fifty-three of the patients had breast cancer, 27--rostate cancer, 6--lung cancer and 1--kidney cancer. The patients were examined for side effects when 32-P was administered perorally and 89-Sr injected intravenously. We also studied the changes in the levels of hemoglobin, white blood cells (WBCs) count and platelets count. RESULTS: We found a significant decrease in the WBC and platelet count in the patients treated with 32-P (U = 2.20, P < 0.05 and U = 4.57, P < 0.001) one month after the therapy. These parameters showed no significant decrease in the group treated with 89-Sr. The pain, which was the rationale to use the radioactive isotopes, was relieved and the patients restored their previous mobility. DISCUSSION: The fact that 32-P alleviated the grave symptom of pain at the relatively weak radiation dose used (2 mCi) is a strong indication that this radiopharmaceutical can be used successfully for such a purpose, although some authors argue against its use in view of the myelosuppresion it causes. This myelosuppression, however, is mild and transient even without treatment and patients could benefit from this adjuvant treatment to manage the pain syndrome. 89-Sr administered intravenously in a dose of 4mCi also relieves pain efficiently but its use is limited by the cost of the quantity needed for 1 patient and for a single dose. The National Health Insurance Fund currently reimburses for a very limited quantity of this substance which makes the cost of the procedure 15 times as expensive as that using radioactive phosphorus. CONCLUSIONS: Using the radiopharmaceuticals 32-P and 89-Sr provides an additional, easy and efficacious means for palliation of cancer patients with bone metastases, especially those who are refractory to percutaneous irradiation." @default.
- W203873669 created "2016-06-24" @default.
- W203873669 creator A5000407431 @default.
- W203873669 creator A5002785274 @default.
- W203873669 creator A5010888714 @default.
- W203873669 creator A5038016710 @default.
- W203873669 creator A5046710630 @default.
- W203873669 creator A5057160517 @default.
- W203873669 creator A5080363248 @default.
- W203873669 date "2005-01-01" @default.
- W203873669 modified "2023-09-27" @default.
- W203873669 title "Radionuclide therapy of cancer patients with bone metastases." @default.
- W203873669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16761397" @default.
- W203873669 hasPublicationYear "2005" @default.
- W203873669 type Work @default.
- W203873669 sameAs 203873669 @default.
- W203873669 citedByCount "0" @default.
- W203873669 crossrefType "journal-article" @default.
- W203873669 hasAuthorship W203873669A5000407431 @default.
- W203873669 hasAuthorship W203873669A5002785274 @default.
- W203873669 hasAuthorship W203873669A5010888714 @default.
- W203873669 hasAuthorship W203873669A5038016710 @default.
- W203873669 hasAuthorship W203873669A5046710630 @default.
- W203873669 hasAuthorship W203873669A5057160517 @default.
- W203873669 hasAuthorship W203873669A5080363248 @default.
- W203873669 hasConcept C121608353 @default.
- W203873669 hasConcept C126322002 @default.
- W203873669 hasConcept C141071460 @default.
- W203873669 hasConcept C2776139714 @default.
- W203873669 hasConcept C2776256026 @default.
- W203873669 hasConcept C2776581026 @default.
- W203873669 hasConcept C2777783956 @default.
- W203873669 hasConcept C2778917026 @default.
- W203873669 hasConcept C2780192828 @default.
- W203873669 hasConcept C2781068499 @default.
- W203873669 hasConcept C29730261 @default.
- W203873669 hasConcept C509974204 @default.
- W203873669 hasConcept C530470458 @default.
- W203873669 hasConcept C71924100 @default.
- W203873669 hasConceptScore W203873669C121608353 @default.
- W203873669 hasConceptScore W203873669C126322002 @default.
- W203873669 hasConceptScore W203873669C141071460 @default.
- W203873669 hasConceptScore W203873669C2776139714 @default.
- W203873669 hasConceptScore W203873669C2776256026 @default.
- W203873669 hasConceptScore W203873669C2776581026 @default.
- W203873669 hasConceptScore W203873669C2777783956 @default.
- W203873669 hasConceptScore W203873669C2778917026 @default.
- W203873669 hasConceptScore W203873669C2780192828 @default.
- W203873669 hasConceptScore W203873669C2781068499 @default.
- W203873669 hasConceptScore W203873669C29730261 @default.
- W203873669 hasConceptScore W203873669C509974204 @default.
- W203873669 hasConceptScore W203873669C530470458 @default.
- W203873669 hasConceptScore W203873669C71924100 @default.
- W203873669 hasLocation W2038736691 @default.
- W203873669 hasLocation W2038736692 @default.
- W203873669 hasOpenAccess W203873669 @default.
- W203873669 hasPrimaryLocation W2038736691 @default.
- W203873669 hasRelatedWork W2023493247 @default.
- W203873669 hasRelatedWork W2041788375 @default.
- W203873669 hasRelatedWork W2055038372 @default.
- W203873669 hasRelatedWork W2086584876 @default.
- W203873669 hasRelatedWork W2301475579 @default.
- W203873669 hasRelatedWork W2349026945 @default.
- W203873669 hasRelatedWork W2354614896 @default.
- W203873669 hasRelatedWork W2363519276 @default.
- W203873669 hasRelatedWork W2364662470 @default.
- W203873669 hasRelatedWork W2365350341 @default.
- W203873669 hasRelatedWork W2384510150 @default.
- W203873669 hasRelatedWork W2390116316 @default.
- W203873669 hasRelatedWork W2395859827 @default.
- W203873669 hasRelatedWork W2405691589 @default.
- W203873669 hasRelatedWork W2412013232 @default.
- W203873669 hasRelatedWork W2415556578 @default.
- W203873669 hasRelatedWork W2588367450 @default.
- W203873669 hasRelatedWork W2607639161 @default.
- W203873669 hasRelatedWork W2977611791 @default.
- W203873669 hasRelatedWork W2172768768 @default.
- W203873669 hasVolume "47" @default.
- W203873669 isParatext "false" @default.
- W203873669 isRetracted "false" @default.
- W203873669 magId "203873669" @default.
- W203873669 workType "article" @default.